Enemsa Pharma
Nantes, FR · 1 known investors
Find your way into Enemsa Pharma
Sign up to see every warm intro you have to Enemsa Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enemsa Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enemsa Pharma is a biopharmaceutical company developing neuroprotective, disease-modifying therapies aimed at restoring cellular homeostasis through proteostasis modulation, mitophagy enhancement and mitochondrial protection. Its treatments target patients with neurodegenerative and neuromuscular disorders such as ALS and CMT, led by its platform asset Icerguastat.
Founders & leadership
PM
Pierre MiniouCo-founder & CEO
EA
Emmanuelle Abgueguen
NC
Noëlle Callizot
PJ
Philippe Jaffré
LM
Lucie Mottier
Investors · 1
Frequently asked questions
- What does Enemsa Pharma do?
- Enemsa Pharma is a biopharmaceutical company developing neuroprotective, disease-modifying therapies aimed at restoring cellular homeostasis through proteostasis modulation, mitophagy enhancement and mitochondrial protection. Its treatments target patients with neurodegenerative and neuromuscular disorders such as ALS and CMT, led by its platform asset Icerguastat.
- Who are Enemsa Pharma's investors?
- Enemsa Pharma's investors include Remiges Ventures, Inc..
- Where is Enemsa Pharma headquartered?
- Enemsa Pharma is headquartered in Nantes, FR.